University&Research Institutions

PARC goes on patent offensive against Facebook, Snap and 推特

Very rare assertion campaign by the Xerox subsidiary sees three suits filed in US district court against social media giants

PARC goes on patent offensive against Facebook, Snap and 推特
US legislators move to close another “evergreening loophole” for orphan drugs
24 十一月 2020

US legislators move to close another “evergreening loophole” for orphan drugs

Recent reforms have made it harder to obtain regulatory exclusivity for follow-on versions of rare disease treatments

Your guide to covid-19 vaccine stakeholders’ IP strategies
19 十一月 2020

Your guide to covid-19 vaccine stakeholders’ IP strategies

我是 examines the approaches taken by – and the issues facing – the leading companies in the race to find effective coronavirus inoculations

最新

查看全部
18 十一月 2020

Samsung taps outside patent lab while spending record amounts on its own R&D

Company is not the only South Korean giant to tap the secondary market as it does more in-house research than ever 阅读更多

17 十一月 2020

Data is the new frontier in healthcare IP licensing, says award-winning TTO

我是 speaks to the tech transfer office of Oregon Health&Science Universityabout the keys to success in university-industry deal-making 阅读更多

10 十一月 2020

There has never been a better time to sell or buy drug royalties, says industry veteran

我是 speaks to leading deal-maker David MacNaughtan about his new fund and the growth of this form of life sciences IP monetisation 阅读更多

9 十一月 2020

Applicants beware: patent oppositions are off the charts in India

Nearly 300% increase over a three-year span indicates greater attention being paid to publications in a jurisdiction where disputes are rising 阅读更多

新闻

查看全部
24 十月 2020

To educate lawyers who change the world, we cannot let this crisis go to waste

As the covid-19 pandemic continues to upend education in the US and beyond, there is an opportunity to create a new normal in how IP is taught, says Megan Carpenter, Dean of the Franklin Pierce School of Law 阅读更多

15 九月 2020

Confronting critical challenges, Taiwan’s tech companies must find a way to create patent value

我是 speaks with IP leaders from Foxconn, AU Optronics and others ahead of IPBC Taiwan next week 阅读更多

14 九月 2020

Changes to Ukraine’s IP laws have major implications for the life sciences

Two recent pieces of legislation have brought the country’s patent system more closely in line with EU rules 阅读更多

12 九月 2020

It’s the PTAB, stupid

Whether the US chooses four more years of Donald Trump or Joe Biden replaces him, big tech's assault on the PTO shows where the patent policy battle lines are being drawn 阅读更多

分析

查看全部
6 十一月 2020

Meet the IV veteran creating an IP licensing business in the pharma space

Connie Wan of Seattle Gummy Company talks to 我是 about the lessons she learned at the mega-NPE 阅读更多

5 十一月 2020

Intel’s legal manoeuvrings illustrate varied NPE threat in China

American chipmaker has faced down a big global licensor, a homegrown NPE and a powerful state-linked research organisation 阅读更多

4 十一月 2020

Amgen suffers another setback in antibody IP war

EPO invalidates PCSK9 patent ahead of crucial CAFC case to be heard next month 阅读更多

27 十月 2020

Health insurer’s damages win against AstraZeneca creates new patent risks in The Netherlands

IP owners are liable to be sued by third parties if they assert rights that are subsequently invalidated, rules Dutch court. 阅读更多

见解

查看全部
12 八月 2020

IP market news highlights

A rundown of some of the top news stories on the 我是 platform in 可能, 君e and July 阅读更多

12 八月 2020

As the fallout from covid continues, the two IP superpowers offer different messages

While China cheers an uptick in applications, the USPTO warns of a prolonged downturn 阅读更多

8 2020

From French fancy to global community – celebrating 100 issues of 我是 

Founder and editor in chief Joff Wild looks back on 17 years of 我是 阅读更多

24 可能 2019

IP market news highlights

Some of the major news stories carried on the 我是 platform from March to mid-May. 阅读更多